Skip to main content
MMED logo

MiniMed Group, Inc.

MMEDNASDAQHealthcareMedical Instruments & Supplies

$18.66Today:- (-)

As of Oct 26, 2026 close

Market cap
$5.24B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$10.65$24.43
Volume (live)
-
Avg. volume (3M)
12.51M

MiniMed Group, Inc. (MMED) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for MiniMed Group, Inc. stock.

Analyst Consensus Rating

Investment consensus from 16 professional research analysts

Consensus Rating

Buy
Based on 16 unique analysts
(21 total ratings in last 90 days)
High Confidence13.0:1 Buy/Sell

Average Price Target

$26.15
+40.14% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest MMED Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Joanne Wuensch
Citi
BuyMaintains
$26.00
Issie Kirby
Rothschild & Co Redburn
BuyInitiates
$30.00
Michael Toomey
Jefferies
HoldInitiates
$22.00
Marie Thibault
BTIG
BuyReiterates
$28.00
Anthony Petrone
Mizuho
BuyMaintains
$26.00 → $28.00
Christopher Pasquale
Barclays
HoldInitiates
$22.00
Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-
Richard Newitter
Truist
BuyInitiates
$29.00
Kallum Titchmarsh
Morgan Stanley
BuyReiterates
$21.00
Steven Lichtman
William Blair
BuyMaintains
-
Larry Biegelsen
Wells Fargo
BuyMaintains
$22.00 → $26.00
Larry Biegelsen
Wells Fargo
BuyMaintains
$22.00 → $26.00
Anthony Petrone
Mizuho
BuyMaintains
$21.00 → $26.00
Pito Chickering
Deutsche Bank
BuyReiterates
$20.00 → $25.00
Patrick Wood
UBS
BuyMaintains
$25.00 → $28.00
Joanne Wuensch
Citi
BuyReiterates
$23.00 → $26.00
Larry Biegelsen
Wells Fargo
BuyInitiates Coverage
$22.00 → $26.00
Daniel Markowitz CFA
Evercore ISI Group
BuyMaintains
$20.00 → $27.00
Marie Thibault
BTIG
BuyReiterates
$25.00 → $28.00
Travis Steed
BofA Securities
BuyReiterates
$24.00 → $28.00
Indrajit Bandyopadhyay
Zacks Equity Research
SellInitiates Coverage
-

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 21, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for MMED?

The analyst consensus rating for MMED is Buy, based on the latest ratings from 16 analysts over the last 90 days.

What is the average price target for MMED?

The average 12-month price target for MMED is $26.15, representing an upside of 40.1% from the Oct 26, 2026 close of $18.66.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.